Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 16.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 47,234 shares of the medical equipment provider’s stock after buying an additional 6,600 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Zimmer Biomet Holdings were worth $6,065,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Enterprise Financial Services Corp increased its stake in Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 9 shares during the last quarter. Sandy Spring Bank increased its position in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 22 shares in the last quarter. Cleararc Capital Inc. increased its position in shares of Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock worth $598,000 after buying an additional 25 shares in the last quarter. Finally, Palladium Partners LLC increased its position in shares of Zimmer Biomet Holdings by 1.7% in the second quarter. Palladium Partners LLC now owns 2,501 shares of the medical equipment provider’s stock worth $321,000 after buying an additional 41 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 113.19 on Friday. The stock has a market cap of $22.89 billion, a price-to-earnings ratio of 32.24 and a beta of 1.20. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The company has a 50-day moving average price of $120.75 and a 200-day moving average price of $120.97.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.95 billion. During the same quarter in the previous year, the company earned $2.02 EPS. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. On average, analysts expect that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.85%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is currently 27.59%.

TRADEMARK VIOLATION NOTICE: This article was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://theolympiareport.com/2017/08/27/fjarde-ap-fonden-fourth-swedish-national-pension-fund-purchases-6600-shares-of-zimmer-biomet-holdings-inc-zbh.html.

A number of brokerages have commented on ZBH. Morgan Stanley boosted their target price on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Stifel Nicolaus reiterated a “hold” rating and issued a $125.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Piper Jaffray Companies reiterated a “buy” rating and issued a $141.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Wells Fargo & Company reiterated a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $140.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four analysts have rated the stock with a sell rating, seven have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $136.75.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Sang Yi sold 17,731 shares of the company’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $124.56, for a total value of $2,208,573.36. The disclosure for this sale can be found here. Corporate insiders own 1.07% of the company’s stock.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.